In recognition of Alzheimer's & Brain Awareness Month, we are excited to highlight novel research that could pave the way for new neurological treatments for diseases like Alzheimer's. A recent publication from Scripps Research Institute has identified new proteins involved in Alzheimer's progression. Utilizing a novel single-cell patch-clamp/proteomics platform, researchers analyzed the electrical patterns and protein levels of individual neurons. They discovered nearly 50 proteins that are differentially expressed in Alzheimer's neurons compared to healthy ones. These findings open exciting avenues for follow-up studies to investigate the potential of these proteins as new drug targets to treat or slow Alzheimer's disease. https://lnkd.in/gyjcxGSF #ENDALZ #Proteomics
So proud to be able to support this key area of research!
Sr. Vice President, Genomics at Discovery Life Sciences
4wReach out if you're advancing research and drug development in Alzheimer's and related neurology disease areas...we can support proteomic lab services for protein biomarker characterization in plasma/serum, CSF, and other critical sample matrices using Olink, Luminex, Seer / Preomics / LC-MS/MS, and other approaches...and are interested in discussing population-based proteomic characterization of large sample cohorts across these technology platforms.